Pfizer PFE Total Alliance revenues — Alliance revenues

Similar metrics at other companies

BMYAlliance revenues — Total Revenues

$94M+6.8%

BMYAlliance and other revenues — Total Revenues

$321M+1.9%

RCUSOther collaboration — Total revenues

$5M-37.5%

ESPRCollaboration revenue — Total Revenues

$36.71M+22.0%

BCRXCollaborative and other revenues — Total revenues

$2M+14.3%

VRDNCollaboration — Total revenues

$135K+35.0%

Questions, answered.

What is Pfizer's total alliance revenues — alliance revenues?

Pfizer (PFE) reported total alliance revenues — alliance revenues of $2.34B in Q1 2026.

How has Pfizer's total alliance revenues — alliance revenues changed year-over-year?

Pfizer's total alliance revenues — alliance revenues increased by 10.7% year-over-year, from $2.11B to $2.34B.

What is the long-term trend for Pfizer's total alliance revenues — alliance revenues?

Over 4 years (2021 to 2025), Pfizer's total alliance revenues — alliance revenues has grown at a 4.9% compound annual growth rate (CAGR), from $7.65B to $9.27B.

What does total alliance revenues — alliance revenues mean?

This metric represents the portion of total revenue generated through collaborative arrangements and strategic partnerships with other pharmaceutical or biotechnology companies. It captures the income derived from co-promotion agreements, profit-sharing models, or royalty streams associated with jointly developed or marketed therapeutic products. This revenue stream is critical for assessing the company's ability to leverage external innovation and share commercialization risks in the drug development lifecycle.